Iodol, a new antiseptic : odourless and without poisonous properties, a substitute for iodoform : German patent no. 35,130 / sole makers Kalle & Co.

  • Kalle & Co.
Date:
[1886]
Catalogue details

Licence: Public Domain Mark

Credit: Iodol, a new antiseptic : odourless and without poisonous properties, a substitute for iodoform : German patent no. 35,130 / sole makers Kalle & Co. Source: Wellcome Collection.

Provider: This material has been provided by The Royal College of Surgeons of England. The original may be consulted at The Royal College of Surgeons of England.

    10/10 (page 8)
    No separation of any l^lackish flakes was noticed, at least to any degree tliat would cause any inconvenience. On the otlier hand, a marked odour of free Iodine was noticeable in a few days in the case of the lodol gauze, which was stored away i'rom the air; from this liberation of iodine, the gauze assumed a gradually increasing brown colour. From the employment of the solution mentioned under heading 3 no good effects were mjticed on the diseased parts. In addition, I would add the following : You observe that on all (essential points I am as satisfied with lodol as Prof. Czerny. I should be very much obliged to you if you would send me a sample of the new substance for further trial. I shall be able to give you then the result much sooner than before, since I now know that certainty of action, and absence of evil results, may be relied on under all circumstances. Berlin, 24th January, 188H. TESTIMONIAL YROM DB. GLA8SNEP, OPHTHALMIC SUBCEON IN CASSEL. I HAVE employed the lodol which you kindly sent me in my o])hthalmic practice, and have arrived at the following results : lodol acts like Iodoform in cases of ulceration of the cornea, when applied in the form of powder ; it acts better than Iodoform for clearing up opacities of the cornea (when applied as an ointment). lodol appears also to have had a favourable effect on some cases of granular lids ; phlectenular processes were cut short by the application of a 2 per cent. lodol ointment. In the employment of the powder, the irritation is at the commencement greater than is the case with iodoform, but it disappears very soon again. Injuries in the neighbourhood of the eye heal very well with lodol powder. I could not observe any local antesthetic effect of the drug. As regards my own special work, I can say that iodol has an equally good effect as Iodoform. If we consider that in the case of the former there is none of that odour which clings to everything, there can be no doubt that lodol will soon replace Iodoform. Cassel, 4th December, 1885. TESTIMONIAL FROM DB. VON HOFFMANN, OPHTHALMIC SURGEON IN BADEN-BADEN. In the past three months I have made observations in the Eye Hospital of Baden-Baden to ascertain whether lodol could not be substituted for Iodoform, on account of the offensive penetrating odour of the latter. I can state that in almost all cases where up to the present Iodoform has been employed, lodol is equally efficacious. The clearing up of infiltrations of the cornea appears to even pro- ceed more rapidly than under the use of Iodoform. The amorphous powder was sprinkled on the conjunctiva, and on the infiltrated and ulcerated parts, several times a day. The eye was then closed and band- aged up, so that the action of the drug was a continuous one. Likewise, it had a marked effect in causing the regressive changes in the granulations in granular conjunctivitis. No difference could be seen between the effect of lodol and Iodoform in plastic operations. The insuffiation of lodol powder effected a rapid cure in two cases of ozeena, which had withstood previous treatment for a long time. If we study the feelings of the patient we shall doubtless choose this apparently equally efficacious remedy. In any case, lodol has the preference on account of its odourless character, and will doubtless be adopted in many hospitals where Iodoform, on account of its objectionable smell, has been abandoned. J. NEIT.T. & 80NS, LITIlOUr.AlMIIf’ PRINTERS, ETC'., 59 & 61, ('rMRERLAND STREET, MANCHESTER.